ACES Diagnostics, Inc. files Form D
Sold rose to $NaN (+$2M, +19 investors) in 630 days since the previous filing.
ACES Diagnostics, Inc., a Delaware corporation incorporated in 2024 and based in Paradise Valley, Arizona, is raising up to $8.7M under Regulation D exemption 506(b). The company has sold $7.08M to 30 investors so far, with $1.62M remaining in the offering.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2024-10-03 | D | $1.6M | 8 | |
| 2026-06-25 | D/A | $3.6M | 27 | +$2M |
| 2026-06-25 | D | $400K | 2 | −$3.2M |
| 2026-10-27 | D | $7.1M | 30 | +$6.7M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor.
Sold rose to $NaN (+$2M, +19 investors) in 630 days since the previous filing.
| Tammy Crawford | Executive Officer, Director |
| Kim Sablich | Director |
| Linda Giampa | Director |
| Todd Snowden | Director |
| John McDonough | Director |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Tammy Crawford, CEO.
The issuer's phone number and address from the filing are shown to subscribers. See plans.